SUSTAINED HIGH PLASMA 5-AMINOLEVULINIC ACID CONCENTRATION IN A VOLUNTEER - NO PORPHYRIC SYMPTOMS

被引:52
作者
MUSTAJOKI, P
TIMONEN, K
GORCHEIN, A
SEPPALAINEN, AM
MATIKAINEN, E
TENHUNEN, R
机构
[1] UNIV HELSINKI, DEPT MED 3, SF-00100 HELSINKI 10, FINLAND
[2] UNIV HELSINKI, DEPT DERMATOL, SF-00100 HELSINKI 10, FINLAND
[3] UNIV HELSINKI, DEPT NEUROL, SF-00100 HELSINKI 10, FINLAND
[4] UNIV HELSINKI, DEPT CLIN CHEM, SF-00100 HELSINKI 10, FINLAND
[5] ST MARYS HOSP, SCH MED, DEPT CLIN PHARMACOL, LONDON, ENGLAND
[6] INST OCCUPAT HLTH, SF-00290 HELSINKI 29, FINLAND
关键词
ACUTE HEPATIC PORPHYRIAS; PATHOGENESIS; 5-AMINOLEVULINIC ACID;
D O I
10.1111/j.1365-2362.1992.tb01482.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pathogenesis of the acute porphyric attack is not known. One hypothesis is that porphyrin precursors, especially 5-aminolaevulinic acid (ALA), are toxic for neuronal tissue. This was tested by infusing ALA in a male volunteer after a loading dose at a rate of 50-80 mg h-1 for 92.5 h. During the experiment plasma ALA concentration was 9-11-mu-mol l-1 and porphobilinogen concentration 3-6-mu-mol l-1 which are the levels seen during acute attacks. Urinary excretion of these porphyrin precursors was also markedly increased. ALA infusion caused no subjective symptoms and no change in pulse rate, blood pressure, or autonomic nerve function or conduction velocity of peripheral nerves. Photosensitivity was not demonstrable. It is concluded that sustained high plasma ALA concentration does not cause porphyria-like symptoms.
引用
收藏
页码:407 / 411
页数:5
相关论文
共 37 条
[1]  
Bonkowsky H L, 1982, Semin Liver Dis, V2, P108, DOI 10.1055/s-2008-1040701
[2]   REPRESSION OF OVERPRODUCTION OF PORPHYRIN PRECURSORS IN ACUTE INTERMITTENT PORPHYRIA BY INTRAVENOUS INFUSIONS OF HEMATIN [J].
BONKOWSKY, HL ;
TSCHUDY, DP ;
COLLINS, A ;
DOHERTY, J ;
BOSSENMAIER, I ;
CARDINAL, R ;
WATSON, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (11) :2725-+
[3]   EFFECT OF HEMATIN IN PORPHYRIC NEUROPATHY [J].
BOSCH, EP ;
PIERACH, CA ;
BOSSENMAIER, I ;
CARDINAL, R ;
THORSON, M .
NEUROLOGY, 1977, 27 (11) :1053-1056
[4]   DETERMINATION OF DELTA-AMINOLEVULINIC ACID IN PLASMA [J].
CHISOLM, JJ .
ANALYTICAL BIOCHEMISTRY, 1968, 22 (01) :54-&
[5]  
DAGG JH, 1965, Q J MED, V34, P163
[6]   EFFECTS OF HEMATIN IN HEPATIC PORPHYRIA - FURTHER STUDIES [J].
DHAR, GJ ;
BOSSENMAIER, I ;
PETRYKA, ZJ ;
CARDINAL, R ;
WATSON, CJ .
ANNALS OF INTERNAL MEDICINE, 1975, 83 (01) :20-30
[7]  
DIVARIS DXG, 1990, AM J PATHOL, V136, P891
[8]  
DOWDLE E, 1968, CLIN SCI, V34, P233
[9]   NEUROPHARMACOLOGY OF DELTA-AMINOLEVULINIC-ACID .2. EFFECT OF CHRONIC ADMINISTRATION IN MICE [J].
EDWARDS, S ;
JACKSON, D ;
REYNOLDSON, J ;
SHANLEY, B .
NEUROSCIENCE LETTERS, 1984, 50 (1-3) :169-173
[10]   DELTA-AMINOLEVULINIC-ACID IN PLASMA, CEREBROSPINAL-FLUID, SALIVA AND ERYTHROCYTES - STUDIES IN NORMAL, UREMIC AND PORPHYRIC SUBJECTS [J].
GORCHEIN, A ;
WEBBER, R .
CLINICAL SCIENCE, 1987, 72 (01) :103-112